Hypogammaglobulinemia following COVID-19 infection in a patient on maintenance rituximab

Hypogammaglobulinemia is a known side-effect of rituximab use. It is typically asymptomatic and transient, although certain factors, such as maintenance dosing and concomitant glucocorticoid use can lead to symptomatic or prolonged hypogammaglobulinemia. Patients with symptomatic hypogammaglobulinem...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Bryan, Collin, Espinosa, Ronald, Chittivelu, Subramanyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679024/
https://www.ncbi.nlm.nih.gov/pubmed/34925841
http://dx.doi.org/10.1177/2050313X211065791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679024/
https://www.ncbi.nlm.nih.gov/pubmed/34925841
http://dx.doi.org/10.1177/2050313X211065791

Ejemplares similares